# DermaSensor Postmarket Surveillance Study

> **NCT06666790** · NA · RECRUITING · sponsor: **DermaSensor, Inc.** · enrollment: 396 (estimated)

## Conditions studied

- Melanoma, Skin

## Interventions

- **DEVICE:** Scan with elastic scattering spectroscopy device to assess risk of malignancy

## Key facts

- **NCT ID:** NCT06666790
- **Lead sponsor:** DermaSensor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-08
- **Primary completion:** 2027-04-11
- **Final completion:** 2027-09-10
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06666790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06666790, "DermaSensor Postmarket Surveillance Study". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT06666790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*